Medical Research Law & Policy Report® Index-Summary

MAINE

– Birth defects, 761

MARYLAND

– Biotechnology

– – Budget, 82
– – Facility construction, 253
– – Johns Hopkins pact with Montgomery County, 147

– Medical care database and data collection, 55
– Nanobiotechnology benefits study, 253
– Stem cell research

– – Funding, 253
– – Pact with Cal., 728

MASSACHUSETTS

– Gift disclosure law, 760

MEDICAL DEVICES

– Agenda from FDA, 787
– Clinical trials, Bayesian statistical methods, 111
– Conflicts of interest, Grassley queries FDA, 697
– Humanitarian use devices, 454
– Imaging device approvals, whistleblowers, 631
– Investigational device exemption, preemption, 752
– New science, FDA workshop, 22
– Parallel review by FDA and CMS, 786
– Pediatric research and medical device applications, 213; rule pulled, 454
– TOGA, investigational use exemption (E.D.N.Y.), 784

MEDICARE

– Evidence development and reimbursement, 174
– Indirect medical education adjustments (7th Cir.), 551
– PET scans for bone metastasis of cancer, 216
– Resident reimbursement and Mich. hospital (E.D. Mich.), 56
– Secondary payers and contract negotiation, 498
– Stem cell treatment coverage, 517
– Warfarin clinical trials, 16

MENTAL HEALTH

– Ohio research rule, 629

MERGERS AND ACQUISITIONS

– deCODE Genetics subsidiary sale, 74

MERIDIA

– Diet drug, withdrawal planned, 650

MICHIGAN

– Stem cell research, spinal surgery coverage (Mich. Ct. App.), 81

MINNESOTA

– Newborn blood screening, 562

MINORITIES

– Disparities, HHS university awards, 623
– Havasupai tribe and Ariz. State Univ., 444; HHS panel examines, 501

MISCONDUCT IN RESEARCH

See RESEARCH AND DEVELOPMENT (R&D)